<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Headache Pain</journal-id><journal-id journal-id-type="iso-abbrev">J Headache Pain</journal-id><journal-title-group><journal-title>The Journal of Headache and Pain</journal-title></journal-title-group><issn pub-type="ppub">1129-2369</issn><issn pub-type="epub">1129-2377</issn><publisher><publisher-name>Springer-Verlag</publisher-name><publisher-loc>Milan</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">17016684</article-id><article-id pub-id-type="pmc">3476082</article-id><article-id pub-id-type="publisher-id">339</article-id><article-id pub-id-type="doi">10.1007/s10194-006-0339-6</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original</subject></subj-group></article-categories><title-group><article-title>Chronic migraine prevention with topiramate</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Peres</surname><given-names>M. F. P.</given-names></name><address><phone>+55-11-81116662</phone><fax>+55-11-32855726</fax><email>marioperes@yahoo.com</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Mercante</surname><given-names>J. P. P.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Tanuri</surname><given-names>F. C.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Nunes</surname><given-names>M.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Zukerman</surname><given-names>E.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label>Instituto Israelita de Ensino e Pesquisa Albert
Einstein, UNIFESP &#x02014; EPM FMABC &#x02014; Department of Neurology, Brazil </aff><aff id="Aff2"><label>2</label>Al. Joaquim Eugenio de Lima, 881 cj 708, 01403-001 S&#x000e3;o Paulo SP, Brazil </aff></contrib-group><pub-date pub-type="epub"><day>4</day><month>9</month><year>2006</year></pub-date><pub-date pub-type="ppub"><month>9</month><year>2006</year></pub-date><volume>7</volume><issue>4</issue><fpage>185</fpage><lpage>187</lpage><history><date date-type="received"><day>23</day><month>4</month><year>2006</year></date><date date-type="accepted"><day>5</day><month>6</month><year>2006</year></date></history><permissions><copyright-statement>&#x000a9; Springer-Verlag
Italia 2006</copyright-statement></permissions><abstract id="Abs1"><p>Chronic migraine (CM) is
a disabling condition with not many
treatment strategies available.
Topiramate is effective in episodic
migraine prevention, however little
is known about its effect in CM. An
open label study was performed.
Sixty-four patients diagnosed with
CM or probable CM according to
the IHS diagnostic criteria were
enrolled, 50 patients were available
for analysis and an intention-to-treat
methodology was applied. The primary
endpoint considered was the
number of patients with a decrease
in headache frequency higher than
50%. The median dose was 100 mg,
a reduction in frequency higher than
50% occurred in 33 patients (66%)
and 14 (28%) presented a complete
response, defined as a frequency
reduction higher than 95%. The
medication was well tolerated. The
most common side effects found
were weight loss, paraesthesias,
nausea, cognitive dysfunction,
fatigue, somnolence, insomnia and
depression. Our findings suggest
that topiramate is effective in CM
prophylaxis.</p></abstract><kwd-group xml:lang="en"><title>Key words</title><kwd>Chronic migraine</kwd><kwd>Prevention</kwd><kwd>Antiepileptic drugs</kwd><kwd>Topiramate</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer-Verlag Italia 2006</meta-value></custom-meta></custom-meta-group></article-meta></front></article>
